The human fatty acid synthase: A new therapeutic target for coxsackievirus B3-induced diseases?

Antiviral Research

Volumn 76, Issue 2, 2007, Pages 150-158

  Rassmann, Alexander ^a   Henke, Andreas ^b   Jarasch, Nadine ^b   Lottspeich, Friedrich ^c   Saluz, Hans Peter ^a   Munder, Thomas ^a  

^a HANS KNÖLL INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

c75; Cerulenin; Coxsackievirus; Fatty acid synthase (FAS); TOFA

Indexed keywords

5 (TETRADECYOXY) 2 FUROIC ACID; C75 PROTEIN; CERULENIN; FATTY ACID SYNTHASE; FATTY ACID SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; COXSACKIE VIRUS B3; DRUG ANTAGONISM; DRUG STRUCTURE; HELA CELL; HUMAN; HUMAN CELL; MYOCARDITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; VIRUS REPLICATION;

4-BUTYROLACTONE; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; CELL LINE; CERULENIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENTEROVIRUS B, HUMAN; ENZYME INHIBITORS; FATTY ACID SYNTHETASE COMPLEX; HUMANS; MOLECULAR SEQUENCE DATA; UP-REGULATION; VIRUS REPLICATION;

ANIMALIA; COXSACKIEVIRUS;

EID: 34548610648     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2007.06.011     Document Type: Article

References (58)

1. Barnard D.L. Current status of anti-picornavirus therapies. Curr. Pharm. Des. 12 (2006) 1379-1390
2. Barton D.J., and Flanegan J.B. Coupled translation and replication of poliovirus RNA in vitro: synthesis of functional 3D polymerase and infectious virus. J. Virol. 67 (1993) 822-831
3. Barton D.J., and Flanegan J.B. Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C. J. Virol. 71 (1997) 8482-8489
4. Barton D.J., Black E.P., and Flanegan J.B. Complete replication of poliovirus in vitro: preinitiation RNA replication complexes require soluble cellular factors for the synthesis of VPg-linked RNA. J. Virol. 69 (1995) 5516-5527
5. Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villén J., Li J., Cohn M.A., Cantley L.C., and Gygi S.P. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 12130-12135
6. Bowles N.E., Richardson P.J., Olsen E.G., and Archard L.C. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1 (1986) 1120-1123
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
8. Bu M., Oroszlan S., and Luftig R.B. Inhibition of bacterially expressed HIV protease activity determined by an in vitro cleavage assay with MuLV Pr65gag. AIDS Res. Hum. Retroviruses 5 (1989) 259-268
9. Doherty N.S., Littman B.H., Reilly K., Swindell A.C., Buss J.M., and Anderson N.L. Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis. Electrophoresis 19 (1998) 355-363
10. Egger D., Wölk B., Gosert R., Bianchi L., Blum H.E., Moradpour D., and Bienz K. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol. 76 (2002) 5974-5984
11. Fogg M.H., Teterina N.L., and Ehrenfeld E. Membrane requirements for uridylylation of the poliovirus VPg protein and viral RNA synthesis in vitro. J. Virol. 77 (2003) 11408-11416
12. Frisk G., Torfason E.G., and Diderholm H. Reverse radioimmunoassays of IgM and IgG antibodies to coxsackie B viruses in patients with acute myopericarditis. J. Med. Virol. 14 (1984) 191-200
13. Funabashi H., Kawaguchi A., Tomoda H., Omura S., Okuda S., and Iwasaki S. Binding site of cerulenin in fatty acid synthetase. J. Biochem. (Tokyo) 105 (1989) 751-755
14. Gebhard J.R., Perry C.M., Harkins S., Lane T., Mena I., Asensio V.C., Campbell I.L., and Whitton J.L. Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am. J. Pathol. 153 (1998) 417-428
15. Gillum R.F. Idiopathic cardiomyopathy in the United States 1970-1982. Am. Heart J. 111 (1986) 752-755
16. Görg A., Obermaier C., Boguth G., Csordas A., Diaz J.J., and Madjar J.J. Very alkaline immobilized pH gradients for two-dimensional electrophoresis of ribosomal and nuclear proteins. Electrophoresis 18 (1997) 328-337
17. Guinea R., and Carrasco L. Phospholipid biosynthesis and poliovirus genome replication, two coupled phenomena. EMBO J. 9 (1990) 2011-2016
18. Halvorson D.L., and McCune S.A. Inhibition of fatty acid synthesis in isolated adipocytes by 5-(tetradecyloxy)-2-furoic acid. Lipids 19 (1984) 851-856
19. Heiligtag S.J., Bredehorst R., and David K.A. Key role of mitochondria in cerulenin-mediated apoptosis. Cell Death Differ. 9 (2002) 1017-1025
20. Henke A., Huber S., Stelzner A., and Whitton J.L. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J. Virol. 69 (1995) 6720-6728
21. Henke A., Launhardt H., Klement K., Stelzner A., Zell R., and Munder T. Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J. Virol. 74 (2000) 4284-4290
22. Henke A., Nestler M., Strunze S., Saluz H.P., Hortschansky P., Menzel B., Martin U., Zell R., Stelzner A., and Munder T. The apoptotic capability of coxsackievirus B3 is influenced by the efficient interaction between the capsid protein VP2 and the proapoptotic host protein Siva. Virology 289 (2001) 15-22
23. Huber S.A., Mortensen A., and Moulton G. Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the gamma delta + T-cell receptor. J. Virol. 70 (1996) 3039-3044
24. Huber S.A., Stone J.E., Wagner D.H., Kupperman J., Pfeiffer L., David C., O'Brien R.L., Davis G.S., and Newell M.K. gamma delta+ T cells regulate major histocompatibility complex class II(IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis. J. Virol. 73 (1999) 5630-5636
25. Knowlton K.U., Jeon E.S., Berkley N., Wessely R., and Huber S. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J. Virol. 70 (1996) 7811-7818
26. Kuhajda F.P., Jenner K., Wood F.D., Hennigar R.A., Jacobs L.B., Dick J.D., and Pasternack G.R. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 6379-6383
27. Kuhajda F.P., Pizer E.S., Li J.N., Mani N.S., Frehywot G.L., and Townsend C.A. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3450-3454
28. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
29. Leipner C., Borchers M., Merkle I., and Stelzner A. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice. J. Hum. Virol. 2 (1999) 102-114
30. Li Y., Webster-Cyriaque J., Tomlinson C.C., Yohe M., and Kenney S. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression. J. Virol. 78 (2004) 4197-4206
31. Liu P., Aitken K., Kong Y.Y., Opavsky M.A., Martino T., Dawood F., Wen W.H., Kozieradzki I., Bachmaier K., Straus D., Mak T.W., and Penninger J.M. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease. Nat. Med. 6 (2000) 429-434
32. Martin U., Nestler M., Munder T., Zell R., Sigusch H.H., and Henke A. Characterization of coxsackievirus B3-caused apoptosis under in vitro conditions. Med. Microbiol. Immunol. 193 (2004) 133-139
33. Mena I., Perry C.M., Harkins S., Rodriguez F., Gebhard J., and Whitton J.L. The role of B lymphocytes in coxsackievirus B3 infection. Am. J. Pathol. 155 (1999) 1205-1215
34. Moche M., Schneider G., Edwards P., Dehesh K., and Lindqvist Y. Structure of the complex between the antibiotic cerulenin and its target, beta-ketoacyl-acyl carrier protein synthase. J. Biol. Chem. 274 (1999) 6031-6034
35. Molla A., Paul A.V., and Wimmer E. Effects of temperature and lipophilic agents on poliovirus formation and RNA synthesis in a cell-free system. J. Virol. 67 (1993) 5932-5938
36. Olivetti G., Abbi R., Quaini F., Kajstura J., Cheng W., Nitahara J.A., Quaini E., Di Loreto C., Beltrami C.A., Krajewski S., Reed J.C., and Anversa P. Apoptosis in the failing human heart. N. Engl. J. Med. 336 (1997) 1131-1141
37. Opavsky M.A., Martino T., Rabinovitch M., Penninger J., Richardson C., Petric M., Trinidad C., Butcher L., Chan J., and Liu P.P. Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J. Clin. Invest. 109 (2002) 1561-1569
38. Pal R., Gallo R.C., and Sarngadharan M.G. Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9283-9286
39. Paul A.V., Peters J., Mugavero J., Yin J., van Boom J.H., and Wimmer E. Biochemical and genetic studies of the VPg uridylylation reaction catalyzed by the RNA polymerase of poliovirus. J. Virol. 77 (2003) 891-904
40. Pereira H.S., and Rebello M.A. Inhibition of Mayaro virus replication by cerulenin in Aedes albopictus cells. Acta Virol. 42 (1998) 383-388
41. Pizer E.S., Thupari J., Han W.F., Pinn M.L., Chrest F.J., Frehywot G.L., Townsend C.A., and Kuhajda F.P. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res. 60 (2000) 213-218
42. Prasad K.V., Ao Z., Yoon Y., Wu M.X., Rizk M., Jacquot S., and Schlossman S.F. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6346-6351
43. Rabilloud T., Valette C., and Lawrence J.J. Sample application by in-gel rehydration improves the resolution of two-dimensional electrophoresis with immobilized pH gradients in the first dimension. Electrophoresis 15 (1994) 1552-1558
44. Rassmann A., Henke A., Zobawa M., Carlsohn M., Saluz H.P., Grabley S., Lottspeich F., and Munder T. Proteome alterations in human host cells infected with coxsackievirus B3. J. Gen. Virol. 87 (2006) 2631-2638
45. Reed L.J., and Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27 (1938) 493-497
46. Rendina A.R., and Cheng D. Characterization of the inactivation of rat fatty acid synthase by C75: inhibition of partial reactions and protection by substrates. Biochem. J. 388 (2005) 895-903
47. Reyes M.P., and Lerner A.M. Coxsackievirus myocarditis-with special reference to acute and chronic effects. Prog. Cardiovasc. Dis. 27 (1985) 373-394
48. Sambrook J., Fritsch E.F., and Maniatis M. Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
49. Sanchez J.C., Rouge V., Pisteur M., Ravier F., Tonella L., Moosmayer M., Wilkins M.R., and Hochstrasser D.F. Improved and simplified in-gel sample application using reswelling of dry immobilized pH gradients. Electrophoresis 18 (1997) 324-327
50. Shimizu H., Agoh M., Agoh Y., Yoshida H., Yoshii K., Yoneyama T., Hagiwara A., and Miyamura T. Mutations in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives. J. Virol. 74 (2000) 4146-4154
51. Si X., Luo H., Morgan A., Zhang J., Wong J., Yuan J., Esfandiarei M., Gao G., Cheung C., and McManus B.M. Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release. J. Virol. 79 (2005) 13875-13881
52. Sugrue D.D., Rodeheffer R.J., Codd M.B., Ballard D.J., Fuster V., and Gersh B.J. The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann. Intern. Med. 117 (1992) 117-123
53. Tomoda H., Kawaguchi A., Omura S., and Okuda S. Cerulenin resistance in a cerulenin-producing fungus. II. Characterization of fatty acid synthetase from Cephalosporium caerulens. J. Biochem. (Tokyo) 95 (1984) 1705-1712
54. Verstrepen W.A., Kuhn S., Kockx M.M., Van De Vyvere M.E., and Mertens A.H. Rapid detection of enterovirus RNA in cerebrospinal fluid specimens with a novel single-tube real-time reverse transcription-PCR assay. J. Clin. Microbiol. 39 (2001) 4093-4096
55. Wakil S.J. Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28 (1989) 4523-4530
56. Wessely R., Henke A., Zell R., Kandolf R., and Knowlton K.U. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 98 (1998) 450-457
57. Wessely R., Klingel K., Santana L.F., Dalton N., Hongo M., Jonathan Lederer W., Kandolf R., and Knowlton K.U. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J. Clin. Invest. 102 (1998) 1444-1453
58. Woodruff J.F. Viral myocarditis. A review. Am. J. Pathol. 101 (1980) 425-484